Related Experiment Video
Updated: May 1, 2026

Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Factors influencing accelerated progression in behavioral variant frontotemporal dementia
Molly Split1,2, Zachary J Kunicki3,4, Daliah Ross3,4
1Department of Psychiatry and Human Behavior, Warren Alpert Medical School of Brown University, Providence, RI, USA. molly_split@brown.edu.
Distinct clinical features predict faster disease progression in behavioral variant frontotemporal dementia (bvFTD). Early-stage bvFTD shows memory and behavioral issues, while later stages show language and motor deficits.
Area of Science:
- Neuroscience
- Clinical Neurology
Background:
- Behavioral variant frontotemporal dementia (bvFTD) is a neurodegenerative disease characterized by progressive decline.
- Identifying factors associated with accelerated disease progression is crucial for patient management and therapeutic development.
Purpose of the Study:
- To identify neuropsychiatric, motor, and cognitive features that predict accelerated disease progression in bvFTD.
- To differentiate predictive markers between mild and moderate stages of bvFTD.
Main Methods:
- 192 participants with bvFTD were classified by disease severity (mild/moderate) using CDR+NACC FTLD scores.
- Progression rate (accelerated vs. non-accelerated) was determined by changes in CDR+NACC FTLD-SB scores.
- Random forest modeling and logistic regression identified predictive features for accelerated progression.
Main Results:
- In mild bvFTD, episodic memory impairment and frontal-behavioral neuropsychiatric symptoms predicted accelerated progression.
- In moderate bvFTD, language impairments and motor signs were the strongest predictors of accelerated progression.
- Identified features significantly improved prediction in mild bvFTD (∆R2=.22, p<.001) and showed a trend in moderate bvFTD (∆R2=.11, p=.08).
Conclusions:
- Distinct clinical profiles predict accelerated progression in mild versus moderate bvFTD.
- Stage-specific clinical markers are important for prognosis and care in bvFTD.
- These findings highlight the need for tailored approaches based on disease severity.
Related Concept Videos
Alzheimer Disease l: Introduction
Alzheimer Disease ll: Pathophysiology
Dementia l: Introduction
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Dementia
The progression of dementia is generally gradual....
Parkinson Disease ll: Pathophysiology

